Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TTK HEALTHCARE - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA TTK HEALTHCARE ASTRAZENECA PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 152.3 70.3 216.5% View Chart
P/BV x 42.8 1.8 2,433.6% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 ASTRAZENECA PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TTK HEALTHCARE
Mar-19
ASTRAZENECA PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,2781,215 105.2%   
Low Rs883610 144.7%   
Sales per share (Unadj.) Rs228.4444.4 51.4%  
Earnings per share (Unadj.) Rs10.417.2 60.1%  
Cash flow per share (Unadj.) Rs16.327.6 58.9%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs98.8177.9 55.5%  
Shares outstanding (eoy) m25.0014.13 176.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.1 230.3%   
Avg P/E ratio x104.252.9 197.0%  
P/CF ratio (eoy) x66.433.0 201.2%  
Price / Book Value ratio x10.95.1 213.3%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m27,00812,894 209.5%   
No. of employees `0001.42.3 58.7%   
Total wages/salary Rs m1,5351,307 117.5%   
Avg. sales/employee Rs Th4,210.92,715.7 155.1%   
Avg. wages/employee Rs Th1,132.2565.3 200.3%   
Avg. net profit/employee Rs Th191.1105.4 181.3%   
INCOME DATA
Net Sales Rs m5,7106,279 90.9%  
Other income Rs m12378 158.1%   
Total revenues Rs m5,8336,356 91.8%   
Gross profit Rs m463496 93.4%  
Depreciation Rs m147147 100.5%   
Interest Rs m034 0.0%   
Profit before tax Rs m438393 111.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m179149 120.1%   
Profit after tax Rs m259244 106.3%  
Gross profit margin %8.17.9 102.7%  
Effective tax rate %40.837.9 107.7%   
Net profit margin %4.53.9 116.9%  
BALANCE SHEET DATA
Current assets Rs m3,2092,717 118.1%   
Current liabilities Rs m2,0701,571 131.7%   
Net working cap to sales %20.018.3 109.3%  
Current ratio x1.61.7 89.6%  
Inventory Days Days7232 225.0%  
Debtors Days Days3547 74.9%  
Net fixed assets Rs m790991 79.7%   
Share capital Rs m50141 35.4%   
"Free" reserves Rs m2,4192,373 102.0%   
Net worth Rs m2,4692,514 98.2%   
Long term debt Rs m03 0.0%   
Total assets Rs m4,6054,158 110.8%  
Interest coverage xNM12.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.5 82.1%   
Return on assets %5.66.7 84.3%  
Return on equity %10.59.7 108.3%  
Return on capital %17.716.9 104.7%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m300225 133.0%   
Fx outflow Rs m2,01571 2,833.5%   
Net fx Rs m-1,715154 -1,113.2%   
CASH FLOW
From Operations Rs m88173 50.8%  
From Investments Rs m-9497 -97.0%  
From Financial Activity Rs mNA-307 0.0%  
Net Cashflow Rs m-6-38 15.1%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 0.3 3.7 8.1%  
FIIs % 15.7 5.2 301.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 9.1 25.8 35.3%  
Shareholders   12,856 12,723 101.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   WYETH  IPCA LABS  NATCO PHARMA  NEULAND LABS  PIRAMAL ENTERPRISES  

Compare ASTRAZENECA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jan 15, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 5-YR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS